Nanjing Vcare's Production Subsidiary Tianshu Pharmaceutical Obtains Japan's AFM Certification

2025-07-30

　　Recently, Hubei Tianshu Pharmaceutical Co., Ltd.(Tianshu Pharmaceutical), the production base subsidiary ofNanjing Vcare Pharmatech Co., Ltd.(Nanjing Vcare), has been granted the Accreditation of Foreign Manufacturers (AFM)(Certification No.: AG10500937) by Japan'sMinistry of Health, Labour and Welfare (MHLW).

　　This certification confirms that Tianshu Pharmaceutical's drug manufacturing facilities, equipment, and quality management system fully comply with Japan's Pharmaceutical Affairs Law requirements. The AFM represents: Official recognition by Japan's regulatory authorities (PMDA and MHLW); A strategic milestone for Tianshu Pharmaceutical's expansion into the Japanese pharmaceutical market; Significant advancement in international API registration capabilities.

 

Prev

Nanjing Vcare Honored as "Best Customer Satisfaction CRO Enterprise"

Next

Nanjing Vcare’s Subsidiary Tianshu Pharmaceutical Honored as "2025 Hubei Provincial Green Factory"